Titre : Désoxyribose

Désoxyribose : Questions médicales fréquentes

Termes MeSH sélectionnés :

Diffusion Tensor Imaging
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Désoxyribose : Questions médicales les plus fréquentes", "headline": "Désoxyribose : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Désoxyribose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-15", "dateModified": "2025-03-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Désoxyribose" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Désoses", "url": "https://questionsmedicales.fr/mesh/D003837", "about": { "@type": "MedicalCondition", "name": "Désoses", "code": { "@type": "MedicalCode", "code": "D003837", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.254" } } }, "about": { "@type": "MedicalCondition", "name": "Désoxyribose", "alternateName": "Deoxyribose", "code": { "@type": "MedicalCode", "code": "D003855", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Zhiqiang Xie", "url": "https://questionsmedicales.fr/author/Zhiqiang%20Xie", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Elemento-Organic Chemistry, Department of Chemical Biology, College of Chemistry, Nankai University, Tianjin 300071, China." } }, { "@type": "Person", "name": "Yuchen Yang", "url": "https://questionsmedicales.fr/author/Yuchen%20Yang", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Elemento-Organic Chemistry, Department of Chemical Biology, College of Chemistry, Nankai University, Tianjin 300071, China." } }, { "@type": "Person", "name": "Zhenghua Wang", "url": "https://questionsmedicales.fr/author/Zhenghua%20Wang", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Elemento-Organic Chemistry, Department of Chemical Biology, College of Chemistry, Nankai University, Tianjin 300071, China." } }, { "@type": "Person", "name": "Dejun Ma", "url": "https://questionsmedicales.fr/author/Dejun%20Ma", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Elemento-Organic Chemistry, Department of Chemical Biology, College of Chemistry, Nankai University, Tianjin 300071, China." } }, { "@type": "Person", "name": "Zhen Xi", "url": "https://questionsmedicales.fr/author/Zhen%20Xi", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Elemento-Organic Chemistry, Department of Chemical Biology, College of Chemistry, Nankai University, Tianjin 300071, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Multiparametric ultrasound imaging for early-stage steatosis: Comparison with magnetic resonance imaging-based proton density fat fraction.", "datePublished": "2023-07-28", "url": "https://questionsmedicales.fr/article/37503961", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/mp.16648" } }, { "@type": "ScholarlyArticle", "name": "Novel Diagnostic Imaging Approach for Patients With Spontaneous Coronary Artery Dissection: The Utility of 18 F-FDG PET Imaging.", "datePublished": "2023-06-29", "url": "https://questionsmedicales.fr/article/37385236", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/RLU.0000000000004762" } }, { "@type": "ScholarlyArticle", "name": "Intracardiac echocardiographic imaging with a cartosound module for guidance of left atrial appendage closure: a comparative study with transesophageal echocardiographic imaging.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37233916", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10554-023-02880-4" } }, { "@type": "ScholarlyArticle", "name": "Can magnetic resonance imaging texture analysis change the breast imaging reporting and data system category of breast lesions?", "datePublished": "2023-03-04", "url": "https://questionsmedicales.fr/article/36889114", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clinimag.2023.02.016" } }, { "@type": "ScholarlyArticle", "name": "Incorporating the synthetic CT image for improving the performance of deformable image registration between planning CT and cone-beam CT.", "datePublished": "2023-02-22", "url": "https://questionsmedicales.fr/article/36910636", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fonc.2023.1127866" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Glucides", "item": "https://questionsmedicales.fr/mesh/D002241" }, { "@type": "ListItem", "position": 3, "name": "Désoses", "item": "https://questionsmedicales.fr/mesh/D003837" }, { "@type": "ListItem", "position": 4, "name": "Désoxyribose", "item": "https://questionsmedicales.fr/mesh/D003855" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Désoxyribose - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Désoxyribose", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Désoxyribose", "description": "Comment le désoxyribose est-il détecté dans le corps ?\nQuels tests mesurent le désoxyribose ?\nLe désoxyribose est-il impliqué dans des maladies ?\nPeut-on mesurer le désoxyribose dans l'urine ?\nQuels sont les marqueurs associés au désoxyribose ?", "url": "https://questionsmedicales.fr/mesh/D003855?mesh_terms=Diffusion+Tensor+Imaging&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Désoxyribose", "description": "Quels symptômes sont liés à un déficit en désoxyribose ?\nLe désoxyribose affecte-t-il le métabolisme ?\nDes symptômes neurologiques peuvent-ils survenir ?\nLe désoxyribose est-il lié à des symptômes immunitaires ?\nQuels signes indiquent un problème avec le désoxyribose ?", "url": "https://questionsmedicales.fr/mesh/D003855?mesh_terms=Diffusion+Tensor+Imaging&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Désoxyribose", "description": "Comment prévenir les troubles liés au désoxyribose ?\nY a-t-il des mesures préventives spécifiques ?\nL'éducation nutritionnelle aide-t-elle ?\nLes dépistages sont-ils utiles ?\nLe mode de vie influence-t-il le désoxyribose ?", "url": "https://questionsmedicales.fr/mesh/D003855?mesh_terms=Diffusion+Tensor+Imaging&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Désoxyribose", "description": "Comment traiter un déficit en désoxyribose ?\nY a-t-il des médicaments pour le désoxyribose ?\nLe désoxyribose peut-il être administré par voie intraveineuse ?\nQuels sont les traitements alternatifs pour le désoxyribose ?\nLe désoxyribose peut-il être utilisé en thérapie génique ?", "url": "https://questionsmedicales.fr/mesh/D003855?mesh_terms=Diffusion+Tensor+Imaging&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Désoxyribose", "description": "Quelles complications peuvent survenir avec un déficit en désoxyribose ?\nLe désoxyribose est-il lié à des cancers ?\nDes problèmes cardiovasculaires peuvent-ils être liés ?\nLe désoxyribose affecte-t-il la fertilité ?\nQuelles sont les conséquences neurologiques possibles ?", "url": "https://questionsmedicales.fr/mesh/D003855?mesh_terms=Diffusion+Tensor+Imaging&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Désoxyribose", "description": "Quels facteurs augmentent le risque de troubles liés au désoxyribose ?\nL'âge influence-t-il le risque ?\nLes maladies métaboliques sont-elles un facteur de risque ?\nLe mode de vie peut-il influencer le risque ?\nLes infections virales sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D003855?mesh_terms=Diffusion+Tensor+Imaging&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment le désoxyribose est-il détecté dans le corps ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le désoxyribose est généralement mesuré par des tests biochimiques sur des échantillons de sang ou de tissus." } }, { "@type": "Question", "name": "Quels tests mesurent le désoxyribose ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et chromatographiques peuvent être utilisés pour quantifier le désoxyribose." } }, { "@type": "Question", "name": "Le désoxyribose est-il impliqué dans des maladies ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans le métabolisme du désoxyribose peuvent être liées à certaines maladies génétiques." } }, { "@type": "Question", "name": "Peut-on mesurer le désoxyribose dans l'urine ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le désoxyribose peut être détecté dans l'urine, mais c'est moins courant que dans le sang." } }, { "@type": "Question", "name": "Quels sont les marqueurs associés au désoxyribose ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs de l'ADN et des acides nucléiques sont souvent associés au désoxyribose." } }, { "@type": "Question", "name": "Quels symptômes sont liés à un déficit en désoxyribose ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Un déficit en désoxyribose peut entraîner des troubles de la croissance et des anomalies cellulaires." } }, { "@type": "Question", "name": "Le désoxyribose affecte-t-il le métabolisme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le désoxyribose est essentiel pour le métabolisme des acides nucléiques et l'énergie cellulaire." } }, { "@type": "Question", "name": "Des symptômes neurologiques peuvent-ils survenir ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans le métabolisme du désoxyribose peuvent être associées à des troubles neurologiques." } }, { "@type": "Question", "name": "Le désoxyribose est-il lié à des symptômes immunitaires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des déséquilibres dans le désoxyribose peuvent affecter la réponse immunitaire, entraînant des symptômes." } }, { "@type": "Question", "name": "Quels signes indiquent un problème avec le désoxyribose ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de fatigue, de faiblesse et des anomalies de croissance peuvent indiquer un problème." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés au désoxyribose ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un suivi médical régulier peuvent aider à prévenir ces troubles." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives spécifiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques peuvent être recommandés pour les familles à risque de troubles liés au désoxyribose." } }, { "@type": "Question", "name": "L'éducation nutritionnelle aide-t-elle ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation nutritionnelle peut sensibiliser aux besoins en désoxyribose et en acides nucléiques." } }, { "@type": "Question", "name": "Les dépistages sont-ils utiles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des dépistages réguliers peuvent aider à identifier précocement les troubles liés au désoxyribose." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le désoxyribose ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une bonne nutrition, peut influencer positivement le métabolisme du désoxyribose." } }, { "@type": "Question", "name": "Comment traiter un déficit en désoxyribose ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des suppléments de désoxyribose et une gestion des symptômes associés." } }, { "@type": "Question", "name": "Y a-t-il des médicaments pour le désoxyribose ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de médicaments spécifiques pour traiter les troubles liés au désoxyribose." } }, { "@type": "Question", "name": "Le désoxyribose peut-il être administré par voie intraveineuse ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, dans certains cas cliniques, le désoxyribose peut être administré par voie intraveineuse." } }, { "@type": "Question", "name": "Quels sont les traitements alternatifs pour le désoxyribose ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des approches nutritionnelles et des thérapies complémentaires peuvent être envisagées." } }, { "@type": "Question", "name": "Le désoxyribose peut-il être utilisé en thérapie génique ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches explorent l'utilisation du désoxyribose dans des thérapies géniques pour certaines maladies." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un déficit en désoxyribose ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des troubles métaboliques et des anomalies de croissance." } }, { "@type": "Question", "name": "Le désoxyribose est-il lié à des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches suggèrent que des anomalies dans le métabolisme du désoxyribose pourraient être liées à certains cancers." } }, { "@type": "Question", "name": "Des problèmes cardiovasculaires peuvent-ils être liés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres dans le désoxyribose peuvent contribuer à des problèmes cardiovasculaires." } }, { "@type": "Question", "name": "Le désoxyribose affecte-t-il la fertilité ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans le métabolisme du désoxyribose peuvent potentiellement affecter la fertilité." } }, { "@type": "Question", "name": "Quelles sont les conséquences neurologiques possibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques peuvent survenir, notamment des troubles cognitifs et moteurs." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de troubles liés au désoxyribose ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de maladies génétiques et une mauvaise nutrition augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles liés au désoxyribose peuvent être plus fréquents chez les jeunes enfants." } }, { "@type": "Question", "name": "Les maladies métaboliques sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies métaboliques peuvent augmenter le risque de troubles liés au désoxyribose." } }, { "@type": "Question", "name": "Le mode de vie peut-il influencer le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sédentaire et une alimentation déséquilibrée peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les infections virales sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales peuvent perturber le métabolisme du désoxyribose, augmentant le risque." } } ] } ] }

Sources (10000 au total)

Multiparametric ultrasound imaging for early-stage steatosis: Comparison with magnetic resonance imaging-based proton density fat fraction.

The prevalence of liver diseases, especially steatosis, requires a more convenient and noninvasive tool for liver diagnosis, which can be a surrogate for the gold standard biopsy. Magnetic resonance (... This study aims to suggest a multiparametric US approach which demonstrates better quantification and imaging performance than MR imaging-based proton density fat fraction (MRI-PDFF) for hepatic steat... We investigated early-stage steatosis to evaluate our approach. An in vivo (within the living) animal study was performed. Fat inclusions were accumulated in the animal livers by feeding a methionine ... The combined US parameter can sensitively assess fat accumulation levels, which is highly correlated with histology fat percentage (R = 0.93, p-value < 0.05) and outperforms the correlation between MR... We demonstrated that fat quantification utilizing a combination of multiple US parameters achieved higher performance than MRI-PDFF; therefore, our multiparametric analysis successfully combined selec...

Intracardiac echocardiographic imaging with a cartosound module for guidance of left atrial appendage closure: a comparative study with transesophageal echocardiographic imaging.

In most clinical trials, intracardiac echocardiography (ICE) has provided fewer views than the four standard views provided by transesophageal echocardiography (TEE) when assessing left atrial appenda... This study prospectively enrolled 202 patients who underwent LAAC using either ICE (n = 69), TEE (n = 121), or a combination of ICE and TEE (n = 12) as the procedural imaging under local anesthesia. A... ICE allowed visualization of the implanted devices in all patients at all proposed angles with long-axis views while two-dimensional (2D) TEE showed short-axis views in 1 or 2 angles in 24.2% of cases... A systematic ICE protocol using a CartoSound module to guide LAAC was reliable for comprehensive long-axis imaging assessment compared with 2D/3D TEE under local anesthesia with a shorter fluoroscopy ...

Can magnetic resonance imaging texture analysis change the breast imaging reporting and data system category of breast lesions?

This study aimed to reveal magnetic resonance imaging (MRI) texture analysis (TA)'s contribution to categorizing breast lesions according to the Breast Imaging-Reporting and Data System (BI-RADS) lexi... Two hundred and seventeen women with BI-RADS category 3, 4, and 5 lesions on breast MRI were included in the study. For TA, the region of interest was drawn manually to encompass the entire lesion on ... Texture parameters extracted from T2WI, including median, gray-level co-occurrence matrix (GLCM) contrast, GLCM correlation, GLCM joint entropy, GLCM sum entropy, and GLCM sum of squares, and paramete... The addition of quantitative parameters obtained by MRI TA to BI-RADS criteria significantly increased the accuracy rate in differentiating benign and malignant breast lesions. When categorizing BI-RA...

Incorporating the synthetic CT image for improving the performance of deformable image registration between planning CT and cone-beam CT.

To develop a contrast learning-based generative (CLG) model for the generation of high-quality synthetic computed tomography (sCT) from low-quality cone-beam CT (CBCT). The CLG model improves the perf... This study included 100 post-breast-conserving patients with the pCT images, CBCT images, and the target contours, which the physicians delineated. The CT images were generated from CBCT images... The DSC, HD95, and ASD of the target contours with the proposed method were 0.87 ± 0.04, 4.55 ± 2.18, and 1.41 ± 0.56, respectively. Compared with the traditional method without the synthetic CT assis... The CLG model proposed in this study can create the high-quality sCT from low-quality CBCT and improve the performance of DIR between the CBCT and the pCT. The target segmentation accuracy is better t...

Image synthesis of effective atomic number images using a deep convolutional neural network-based generative adversarial network.

The effective atomic numbers obtained from dual-energy computed tomography (DECT) can aid in characterization of materials. In this study, an effective atomic number image reconstructed from a DECT im... The image synthesis framework to obtain the effective atomic number images from a single-energy CT image at 120 kVp using a CNN-based GAN was developed. The evaluation metrics were the mean absolute e... The difference between the reference and synthetic effective atomic numbers was within 9.7% in all regions of interest. The averages of MAE, RMSE, MSE, SSIM, PSNR, and MI of the reference and synthesi... In this study, an image synthesis framework using single-energy CT images was constructed to obtain atomic number images scanned by DECT. This image synthesis framework can aid in material decompositi...

Comparative Effectiveness of Magnetic Resonance Imaging-Ultrasound Fusion Versus In-bore Magnetic Resonance Imaging-targeted Prostate Biopsy.

To examine the comparative effectiveness of magnetic resonance imaging-ultrasound (MRI-U/S) fusion biopsy and in-bore MRI-targeted biopsy.... We identified men aged 18-89 with a diagnosis of elevated prostate specific antigen (PSA) or Gleason 6 prostate cancer on active surveillance who underwent MRI-U/S fusion prostate biopsy (12-core + ta... A total of 280 patients (346 lesions) were included, of whom 23.9% were on active surveillance for Gleason 6 prostate cancer. In the per-patient analyses, there was no statistically significant differ... We observed no statistically significant differences in cancer detection rates between MRI-U/S fusion biopsy and MRI-IB biopsy in per-patient analyses. However, MRI-IB biopsy was associated with highe...